Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- Pepeto presale crossed $8.47 million after its latest presale round closed ahead of schedule, and the crypto news connecting this project to the BNB...
-
Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- Pepeto pushed past $8.47 million after its latest round closed ahead of schedule while the crypto news today delivered the catalysts this bull run has...
-
Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- The Pepeto team confirmed a major update to the exchange infrastructure as the presale pushes past $8.47 million with entries arriving faster every...
-
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GSI...
-
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lakeland Industries, Inc. (NASDAQ: LAKE) between December...
-
Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- Pepeto crossed $8.47 million in presale capital with stages selling out faster every round, and the wallets entering this project are not retail...
-
Gelatin trick 2026 warning: does the viral gelatin trick recipe work? Pink gelatin trick, ice gelatin trick, and Gelatine Sculpt examined.
-
2026 SteelPower performance report covers male enhancement formula details, ingredient research context, pricing, and guarantee disclosures.
-
The results of the Phase 3 VALOR trial were published in the New England Journal of Medicine, underscoring the practice-changing potential of brepocitinib 30 mg once-daily in...
-
In the Phase 2 part of the AMETHYST study, litifilimab met the primary endpoint of reduction of disease activity in people living with CLE at Week 16, with more litifilimab participants achieving...